Valencia Quintero JS, Castillo D. Venglustat, Lanreotide Acetate, and Tolvaptan as therapeutic options for the treatment of autosomic dominant polychistic kidney disease: a narrative review. Interdiscip J Epidemiol Pub Health [Internet]. 2021 Apr. 12 [cited 2025 Mar. 11];3(2):e-7246. Available from: https://revistas.unilibre.edu.co/index.php/iJEPH/article/view/7246